ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Challenge finalist: Versantis (Switzerland)

The liver is a vital organ that performs multiple functions to keep the body free of toxins. Liver failure is often fatal. Versantis is developing a treatment that brings new hope to people with hepatic diseases.

     Its VS-01 therapy is a breakthrough in peritoneal dialysis. Its pH-gradient liposomes -- spherical vesicles composed of a phospholipid bilayer -- enhance the clearance of toxins such as ammonia. "Our product is more effective, safer and detoxifies patients' blood faster," the company says.

     Versantis expects to begin key trials in three years and is aiming for market approval in Europe in 2021, followed by approval and commercialization in Asia and the U.S.

     "By opening up new dimensions in the field of dialysis with a different approach, our mission is to save and improve the lives of liver patients worldwide, every day," said CEO Vincent Forster.

     According to the Pioneers Asia jury, Versantis is addressing a serious problem that has previously been neglected, with a very strong team and expertise. 

CEO: Vincent Forster

http://www.versantis.ch/

Twenty-four finalists will be chosen for Pioneers Asia Challenge, the main competition for advanced-stage startups. The Nikkei Asian Review will feature three finalists each week; this is the second week of entries from Europe, which had an earlier deadline for entry than those from Asia. The two other categories of competition -- Pioneers 90 Seconds Pitch and Pioneers Showroom -- are for seed and earlier-stage startups.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more